Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|August 31, 2022
The Use of Renal Biomarkers in Pediatric Cardiac Patients With Acute Kidney InjuryChristopher L Shaffer
Clinical Pharmacology and Therapeutics|October 28, 2017
Reverse and Forward Translational Neuropharmacology in Psychiatric Drug DiscoveryChristopher L Shaffer
Journal of Pharmaceutical and Biomedical Analysis|December 8, 2006
Metabolism of a 14C/3H-labeled GABAA receptor partial agonist in rat, dog and human liver microsomes: evaluation of a dual-radiolabel strategyChristopher L Shaffer, Connie S Langer
Mass Spectrometry Reviews|April 4, 2007
Analytical strategies for identifying drug metabolitesChandra Prakash, Christopher L Shaffer, Angus Nedderman
Bioanalysis|November 5, 2013
The effect of ketamine-contaminated control plasma on small-molecule plasma protein bindingSarah M Osgood, Jianhua Liu, Christopher L Shaffer
Medical & Biological Engineering & Computing|May 12, 2017
Insights from mathematical modeling for convection-enhanced intraputamenal delivery of GDNFElena Belova, Christopher L Shaffer, Patrick E Trapa
Journal of Biomolecular Structure & Dynamics|January 2, 2023
GB1 hairpin kinetics: capturing the folding pathway with molecular dynamics, replica exchange and optimal dimensionality reductionKrzysztof Kuczera, Robert Szoszkiewicz, Christopher L Shaffer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 21, 2007
Metabolism and disposition of a selective alpha(7) nicotinic acetylcholine receptor agonist in humansChristopher L Shaffer, Mithat Gunduz, Renato J Scialis, et al.
Journal of the American Chemical Society|July 11, 2002
Formation of cyclopropanone during cytochrome P450-catalyzed N-dealkylation of a cyclopropylamineChristopher L Shaffer, Shawn Harriman, Yakov M Koen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2009
Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound dispositionChristopher L Shaffer, Mithat Gunduz, Tim F Ryder, et al.
Pageof 5